← Insider buys
RARE

Ultragenyx Pharmaceutical Inc. · Healthcare

CFO Howard Horn sold $117K of Ultragenyx Pharmaceutical Inc.

Sold$116,607
$24.90Price
4,683Shares
−4%Stake

What RARE did after the filing

Filed May 4Copier in May 5
The stock from Tue, May 5 open, $24.96
+7.8%
S&P 500, same days
+2.7%

Measured over 30 trading days, to the Jun 17 close.

Traded Fri, May 1. Filed Mon, May 4, 5:35 PM ET, after the close. Returns use the May 5 open and the Jun 17 close. Not investment advice.